Myalgia: Clinical Trials

10 trials for Myalgia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 10

Follow Myalgia: new trials by email Literature Review of Myalgia trials Research Report on Myalgia

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19
BNO 1030, Standard care - Covid19, Nasopharyngitis
Phase 4CompletedIvano-Frankivsk National Medical University1332020-05-012021-03-15
Ibuprofen Versus Placebo For Muscle Soreness
Ibuprofen 400 mg, Placebo - Muscle Soreness
Phase 4CompletedJean Brown Research312017-04-102017-08-04
Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
Buprenorphine Transdermal Patch - Osteoarthritis, Rheumatoid Arthritis
Phase 4CompletedMundipharma Pharmaceuticals Sdn. Bhd.782013-07-012016-07-20
Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
Buprenorphine transdermal patch - Osteoarthritis, Rheumatoid Arthritis
Phase 4CompletedMundipharma Pte Ltd.1142013-06-012016-09-23
Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise
Wobenzym® plus, Placebo - Muscle Injury, Muscle Soreness
Phase 4CompletedMucos Pharma GmbH & Co. KG692013-02-012015-08-28
Coenzyme Q10 in Older Athletes Treated With Statin Medications
Coenzyme q 10, placebo - Muscle Weakness, Myalgia
Phase 4CompletedRichard Deichmann, MD202009-11-012012-05-03
Hood to Coast Injury Study
Tart Cherry Juice, Fruit juice - Pain
Phase 4CompletedOregon Health and Science University652008-08-012019-06-20
The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy
Q10, Selen - Statin Therapy
Phase 4CompletedOslo University Hospital402005-05-012011-07-01
An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.
acetaminophen extended release caplets - Pain
Phase 4CompletedJohnson & Johnson Consumer and Personal Products Worldwide4832003-05-012011-06-29
An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon Race
acetaminophen extended release - Pain
Phase 4CompletedJohnson & Johnson Consumer and Personal Products Worldwide6652015-06-19

Narrower conditions

Pain (3)  ·  Arthralgia (2)  ·  Arthritis, Rheumatoid (2)  ·  Low Back Pain (2)  ·  Osteoarthritis (2)  ·  Anosmia (1)  ·  COVID-19 (1)  ·  Chronic Pain (1)  ·  Cough (1)  ·  Fever (1)  ·  Inflammation (1)  ·  Muscle Weakness (1)  ·  Nasal Obstruction (1)  ·  Nasopharyngitis (1)

Broader conditions

Muscular Diseases (10)  ·  Musculoskeletal Diseases (10)  ·  Musculoskeletal Pain (10)  ·  Nervous System Diseases (10)  ·  Neurologic Manifestations (10)  ·  Neuromuscular Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (10)  ·  Pain (7)  ·  Arthritis (2)  ·  Autoimmune Diseases (2)  ·  Back Pain (2)  ·  Connective Tissue Diseases (2)  ·  Immune System Diseases (2)  ·  Joint Diseases (2)

Interventions

Fruit and Vegetable Juices (1)  ·  Ibuprofen (1)  ·  Selenium (1)  ·  Standard of Care (1)  ·  Tuberculin (1)  ·  Wobenzym (1)  ·  coenzyme Q10 (1)  ·  imupret (1)

Sponsors

Johnson & Johnson Consumer and Personal Products Worldwide (2)  ·  Ivano-Frankivsk National Medical University (1)  ·  Jean Brown Research (1)  ·  Mucos Pharma GmbH & Co. KG (1)  ·  Mundipharma Pharmaceuticals Sdn. Bhd. (1)  ·  Mundipharma Pte Ltd. (1)  ·  Oregon Health and Science University (1)  ·  Oslo University Hospital (1)  ·  Richard Deichmann, MD (1)

Countries

United States (2)  ·  Germany (1)  ·  Hong Kong (1)  ·  Malaysia (1)  ·  Norway (1)  ·  Philippines (1)  ·  South Korea (1)  ·  Ukraine (1)

Top investigators

Helmut Pabst, Dr. med (1)  ·  Kerry S Kuehl, MD (1)  ·  Richard Deichmann, MD (1)  ·  Vasyl Popovych, Professor (1)

Results publications

PMID 28778219

NIH funding

2004 (1)